The effect of pentazocine 40 mg on pupillary size and reaction was investigated and compared with morphine 15 mg in 20 conscious patients. Pentazocine produced less pupilary constriction and the pupillary reaction to light was preserved. The effect of pentazocine on intracranial pressure was studied in 8 anaesthetized ventilated patients. Pentazocine was found to cause a small fall in intracranial pressure despite the fact that blood pressure and Paoo 3 were unaltered. The effect of pentazocine on intracranial pressure was studied in 11 spontaneously breathing patients with brain damage. Pentazocine caused an increase in intracranial pressure in 9 patients which was probably due to a rise in Pac 02 -The increase was least when the initial level of intracranial pressure was low. Pentazocine, therefore, may have a place in the relief of pain in head injuries. Measurements of respiratory depression and ventricular fluid pressure after administration, however, suggest that caution be excercised and the drug may best be used in small intravenous doses.
A third of patients with severe head injury have additionally suffered other major trauma (Lewin, 1966) and although not fully conscious may have considerable pain which is difficult both to recognize and to manage. Such pain may contribute to restlessness in the unconscious patient but, even after urinary retention and increasing intracranial pressure have been excluded as causes, powerful analgesics are often witheld because there is concern about depression of the conscious level, alteration of pupillary size and response, further increase of intracranial pressure or respiratory depression. This dilemma is well illustrated by a recent enquiry (Any Questions? 1969) on the choice of analgesics for these patients. Pethidine and morphine were suggested as the best available drugs, although both may produce severe medullary depression in the normal patient and, even in small doses may adversely affect the patient who already has brain damage.
If mild analgesics such as aspirin or codeine are thought to be inadequate, attempts may be made to sedate these patients with small doses of nonanalgesic drugs such as phenobarbitone, paraldehyde, diazepam or the phenothiazine derivatives, but repeated administration of these can cause prolonged depression of consciousness which makes neurological assessment difficult. In addition, phenothiazines can cause pupillary inequality (Corssen and Domino, 1964) and both they and the barbiturates may exert an antanalgesic action (Dundee, 1960; Moore and Dundee, 1961) .
In order to investigate the possibility that some of the newer powerful analgesics might have significant advantages over the older drugs, it was decided to compare the effects of pentazocine (Fortral) with morphine, a well-known pupilloconstrictor, on pupillary size and to study the effect of pentazocine on intracranial pressure. Since the effect of morphine on intracranial pressure has been ascribed entirely to an increase in arterial Pco 2 (Pacoi) due to respiratory depression (Weitzner, McCoy and Binder, 1963) we have examined the effect of pentazocine on intracranial pressure in patients breathing spontaneously and those in whom respiration was controlled.
PATIENTS AND METHODS
Pupillary size. Twenty patients about to undergo surgery for a prolapsed intervertebral disc, who were free of any known intracranial disease and had normal equal pupils, were studied. Ten patients received morphine 15 mg over 1^-2 minutes into the intravenous drip and 10 received pentazocine 40 mg at a similar rate: no other drugs were administered. Pupil diameter was measured before, and 10 minutes after, the end of the injection using a Davis Keeler pupillometer which has a sliding marker on a millimetre scale ( fig. X Ventricular fluid pressure (v.f.p.) measurements. Controlled ventilation. Measurements were made on 8 patients undergoing intracranial operations for space-occupying lesions. All received premedication with atropine 0.6 mg and pethidine 50 mg unless the patient was already drowsy. If there were signs of increased intracranial pressure only atropine 0.6 mg was given. Anaesthesia was induced with thiopentone and, after injecting alcuronium 20 mg, controlled ventilation with nitrous oxide and oxygen was instituted; further 10 mg doses of alcuronium were administered at regular intervals. Ventilation was adjusted by reference to the Nunn blood-gas predictor to aim at normocapnia (Nunn, 1962) , and the end-tidal Pco, monitored by continuous recording from the endotracheal tube using an infra-red analyzer; Pa C 02 was measured using a direct reading electrode (Radiometer) at the beginning and at the end of the period of observation. Lower oesophageal temperature was recorded to allow correction of the Pa C o 2 for temperature differences between the patient and the electrode system using the Severinghaus slide-rule. The patient was draped for the planned procedure with the table horizontal. The first burr-hole was made and measurements of ventricular fluid pressure were recorded from a metal brain cannula inserted through this burr-hole into the lateral ventricle. A fine catheter filled with saline was connected from the cannula to a saline manometer or, in 5 patients, to a pressure transducer and a chart recorder. Care was taken to avoid loss of cerebrospinal fluid during connection of the catheter to the cannula. For consistency in the presentation of results the saline measurements have been converted to mm Hg. Blood pressure was measured by continuous intra-arterial recording or, in 3 patients, by upper arm sphygmomanometry.
As soon as the ventricular fluid pressure was stable pentazocine 40 mg was given over 1^-2 minutes intravenously and the pressure measured continuously for 10 minutes. Measurements were not started until at least 1 hour had elapsed after induction and therefore any effect due to premedicants or thiopentone would be minimal. In some cases the effect of 1 per cent halothane was observed for a further 5 minutes.
Spontaneous respiration. It is the practice in this Institute to measure ventricular fluid pressure continuously over prolonged periods in patients suffering from severe head injury or after the clipping of an intracranial aneurysm (Johnston, Johnston and Jennett, 1970) . In 11 such patients exhibiting marked restlessness, the opportunity was taken to study the effects on ventricular fluid pressure of pentazocine 10 mg given by slow intravenous injection; no previous opiate had been given. Mean ventricular fluid pressure, defined as (systolic+ 2 diastolic)/3 was assessed over a period of 15 minutes before administration and compared with the mean pressure for a similar period after drug administration. Pac O2 was measured in 8 of the 11 patients immediately before and 15 minutes after the end of the injection.
RESULTS

Pupillary size.
The results for the pentazocine and morphine treated groups are shown in table I together with the mean change and the difference between these values. The changes were equal on both sides. Pentazocine produced constriction of the pupil which was significantly less (P<0.05) than that produced by morphine; the pupillary reaction to light was preserved in all patients.
Ventricular fluid pressure changes with controlled respiration. Table II shows the changes in ventricular fluid pressure, Pac 02 and arterial pressure in the 8 patients. In no instance was there an increase in ventricular fluid pressure 10 minutes after injection of pentazocine and in some patients there was a decrease. Changes in Pa CO 2 were minimal. Arterial pressure changes occurred in some patients but only 1 patient showed a change of more than 10 mm Hg. This patient had a fall of 20 mm Hg 10 minutes after the injection which was associated with the fall in ventricular fluid pressure of 6.5 mm Hg. Changes in mean blood pressure were of no clinical or statistical significance. In 5 patients the addition of halothane 1 per cent produced a marked increase in ventricular fluid pressure ( fig. 2 ) which was not associated with any change in Pa C02 , but indicated that cerebral vasoreactivity was present.
Spontaneous respiration. Table III shows the changes in ventricular fluid pressure assessed at 3-minute intervals for the 15-minute period both before and after injection, together with changes in Pa C02 in 8 of the patients. Only 1 patient showed a decrease in ventricular fluid pressure while the remainder showed an increase in pressure. This was associated with an increase in Pac 03 . There was no consistent relationship between the degree of increase in Pa co , and the rise in pressure but the increase in intracranial pressure was more pronounced in those patients in whom it was initially elevated (greater than 10 mm Hg) (P<0.01).
DISCUSSION
The effect of morphine on the pupil is thought to be caused by direct stimulation of the oculomotor nucleus or the pupilloconstrictor centre. In normal subjects the opioid antagonists nalorphine and levallorphan also produce miosis, but if given to a subject dependent on morphine they antagonize the existing miosis, producing mydriasis (Martin, 1967) . Pentazocine is a weak morphine antagonist and Fraser and Rosenberg (1964) found that the miosis produced by In these studies the drugs were given by subcutaneous injection to former opiate addicts which may explain the different response found in our study.
The effect of pentazocine on intracranial pressure is similar to that of fentanyl. Fitch and associates (1969) suggested that the moderate fall in intracranial pressure produced by fentanyl could be accounted for by the reduction in cerebral metabolism resulting in a reduction in cerebral blood flow. Miller and Barker (1969) however, showed that in dogs fentanyl and droperidol in combination reduced cerebral blood flow without causing any significant change in cerebral oxygen consumption and postulated a vasoconstrictive action. Jennett, Barker and Forrest (1968) have demonstrated a much smaller reduction in total oxygen consumption with pentazocine than with phenoperidine or morphine. The important point is that in patients these analgesics do not by themselves directly produce a rise in intracranial pressure. This is in contrast to the volatile agents, halothane, trichloroethylene and methoxyflurane, which cause a rise in ventricular fluid pressure most marked in patients with cerebral tumours . Figure 2 shows the response to halothane after the administration of pentazocine.
Pentazocine, phenoperidine or fentanyl may be used to supplement nitrous oxide and oxygen in general anaesthesia, and have been used as analgesics in neuroleptanalgesia. In operative procedures in patients with head injury this analgesia may be carried over into the postoperative period and makes for a more easily managed patient. In the spontaneously breathing patient with raised intracranial pressure, however, it is possible that full doses of the drug may produce a degree of respiratory depression which may further increase intracranial pressure. In such circumstances small, infrequent, intravenous doses are best given in the manner to be discussed later.
It must be stressed that the first group of ventricular fluid pressure studies was concerned with patients in whom ventilation was controlled so as to exclude any change in intracranial pressure as a result of alterations in Pa c02 . The second group of studies was carried out in order to assess the clinical safety of administration of pentazocine to spontaneously breathing patients when a rise in intracranial pressure might occur due to a rise in Pa C o 2 -In the patient breathing spontaneously the effect of pentazocine seems to depend on the initial pressure: when this is low the administration of pentazocine has little effect on ventricular fluid pressure, but if the intracranial pressure/volume curve (Langfitt, 1969) is in the steeply rising phase the cerebral vasodilatation produced by the increase in Paco 2 may produce a marked rise in pressure.
The respiratory effects of pentazocine have recently been compared with those of pethidine, morphine and phenoperidine (Engineer and Jennett, 1972, in preparation; Jennett, Barker and Forrest, 1968) . The opioid drugs produced an irregular irregularity in the respiratory pattern which was very similar to that described by Plum (1960) in certain medullary lesions. There was considerably less effect on the respiratory pattern with equianalgesic doses of pentazocine. Furthermore, a recent study by Davie, Scott and Stephen (1970) has shown that small doses of pentazocine 30 mg do not produce a cumulative respiratory depression while the same doses of pethidine have a marked cumulative respiratory depressant effect.
It is interesting to note that a further query has been raised (Any Questions? 1971) concerning the use of analgesics in cases of injury and in this instance pentazocine has been recommended as the drug of choice because it does not produce hypotension and causes less nausea and vomiting than pethidine. On the basis of our results it would seem that pentazocine would be preferable to the opioid drugs for the relief of pain in patients with head injuries. The masking of the neurological signs such as pupil size and the respiratory depression produced by pentazocine appears to be less confusing and of shorter duration than with the opioids. Nevertheless it is probably prudent to suggest that this analgesic should be used in head injuries only in small doses intravenously when intracranial pressure monitoring is being carried out or is known to have been controlled, for example by evacuation of a haematoma.
SOMMAIRE
Les effets engendres par une dose de 40 mg de pentazocine sur les dimensions de la pupille et sur la reaction pupillaire ont ete etudies et compares a ceux entraines par une dose de 15 mg de morphine, chez 20 malades presentant un etat conscient. La pentazocine a provoque une contraction pupillaire moindre et la reaction pupillaire a la lumiere a ete conservee. L'effet de la pentazocine vis-a-vis de la pression intra-cranienne a ete etudie chez 8 malades soumis a une anesthesie par inhalation. On a constate que la pentazocine entrainait une legere chute de la pression intra-cranienne en depit du fait que la pression arterielle et la tension en gaz carbonique Paco 3 etaient demeurees inchangees. L'effet de la pentazocine sur la pression intra-cranienne a ete etudie chez onze malades atteints de lesions cerebrales et presentant une respiration spontanee. La pentazocine a provoque une elevation de la pression intra-cranienne chez neuf malades, due probablement a un accroissement de la tension Paco 2 du gaz carbonique. Cette augmentation a ete moindre lorsque la valeur initiate de la pression intra-cranienne etait basse. La pentazocine peut, de ce fait, trouver une place en vue du traitement de la douleur provoquee par des blessures de la tete. Toutefois, les mesures de la depression respiratoire et de la pression du liquide ventriculaire effectuees apres administration du medicament, suggerent qu'une prudence est de mise et que la medication devrait etre de'preference utilisee a faibles doses par voie intraveineuse. 
INTRACRANEAL
RESUMEN
El efecto de 40 mg de pentazocina sobre el tamano y reaction de las pupilas fue investigado y comparado con 15 mg de morfina en veinte pacientes conscientes. La pentazocina produjo menos contracci6n pupilar y fue conservada la reaccion pupilar a la luz. El efecto de la pentazocina sobre la presion intracraneal fue estudiado en ocho pacientes ventilados anestesiados. Se encontr6 que la pentazocina ocasiona un descenso de la presion intracraneal a pesar del hecho de que no son modificadas la presion arterial y Paco 2 . El efecto de la pentazocina sobre la presi6n intracraneal fue estudiado en once pacientes con lesion cerebral que respiraban espontaneamente. La pentazocina causo un aumento de la presi6n intracraneal en nueve pacientes que probablemente era debido a una elevaci6n de la Paco 2 . El incremento fue menor cuando el nivel initial de presi6n intracraneal era bajo. Asi pues, la pentazocina pudiera tener un lugar en el alivio del dolor en lesiones craneales. Sin embargo, las mediciones de la depresi6n respiratoria y presi6n del liquido ventricular despues de su administracion sugieren que hay que tener cuidado y que es mejor utuizar el medicamento en pequefias dosis intravenosas.
